Lv3
251 积分 2021-07-16 加入
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer
2天前
已完结
Single‐cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile
2天前
已完结
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
17天前
已完结
Single-cell RNA sequencing reveals that HSD17B2 in cancer-associated fibroblasts promotes the development and progression of castration-resistant prostate cancer
1个月前
已完结
Ketogenesis instigates immune suppression in enzalutamide resistant prostate cancer via OTUD7B β-hydroxybutyrylation
1个月前
已完结
[Consensus on the molecular residual disease testing in solid tumor]
1个月前
已完结
实体瘤分子残留病灶检测共识
1个月前
已关闭
胃癌分子残留病灶检测与临床应用中国专家共识（2023版）
1个月前
已完结
结直肠癌分子病理检测临床实践指南
1个月前
已完结
Therapeutic landscape and future direction of metastatic colorectal cancer
1个月前
已完结
皖公网安备34019202002308
